ESR1 and breast cancer: As previously reported, c-Myc and Cyclin D1 were strongly associated with the development of tamoxifen resistance5, 18, we wanted to know whether miR-320a and its targets could also be involved in the regulation of tamoxifen sensitivity in ER+ breast cancer cells.